Vir Biotechnology, Inc. (VIR)
NASDAQ: VIR · Real-Time Price · USD
10.60
-0.32 (-2.93%)
At close: Sep 18, 2026, 4:00 PM EDT
10.50
-0.10 (-0.94%)
After-hours: Sep 18, 2026, 7:30 PM EDT
Vir Biotechnology Stock Forecast
Stock Price Forecast
According to 10 analysts polled by S&P Global, Vir Biotechnology stock has a consensus rating of "Strong Buy" and an average price target of $20.78. The average 1-year stock price forecast is 96.04% higher than the current stock price, while the lowest is $15 (+41.51%) and the highest is $30 (+183.02%).
Price Target: $20.78 (+96.04%)
Analyst Consensus: Strong Buy
Price Target
Chart* Price targets were last updated on Aug 10, 2026.
Analyst Ratings
The average analyst rating for Vir Biotechnology stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 | Sep '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 7 | 7 | 7 | 7 | 7 | 7 |
| Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 10 | 10 | 10 | 10 | 10 | 10 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $20 | Buy | Reiterates | $20 | +88.68% | Aug 10, 2026 |
| Bank of America Securities | Bank of America Securities | Buy Reiterates $16 → $15 | Buy | Reiterates | $16 → $15 | +41.51% | Aug 7, 2026 |
| Evercore ISI | Evercore ISI | Buy Maintains $22 | Buy | Maintains | $22 | +107.55% | Aug 6, 2026 |
| Needham | Needham | Buy Reiterates $18 | Buy | Reiterates | $18 | +69.81% | Aug 6, 2026 |
| Morgan Stanley | Morgan Stanley | Buy Reiterates $27 → $25 | Buy | Reiterates | $27 → $25 | +135.85% | Aug 6, 2026 |
Financial Forecast
Revenue This Year
245.24M
from 68.56M
Increased by 257.73%
Revenue Next Year
73.59M
from 245.24M
Decreased by -69.99%
EPS This Year
-1.76
from -3.16
EPS Next Year
-2.49
from -1.76
EPS and Forward PE are based on non-GAAP adjusted numbers.